RPTX NASDAQ
Repare Therapeutics Inc.
1W: +19.8%
1M: +22.1%
3M: +45.2%
1Y: +101.5%
3Y: -82.1%
5Y: -92.2%
$2.65
Last traded 2025-12-31 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$76M
+39.9% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$76M
+40.8% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$27M
+45.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$53M | -$107M | -$29M | -$94M | -$85M |
| Depreciation & Amort. | $897K | $1M | $2M | $2M | $2M |
| Stock-Based Comp. | $3M | $13M | $20M | $25M | $23M |
| Change in Working Capital | $42M | $5M | $8M | -$55M | -$14M |
| Other Non-Cash Items | $890K | $2M | -$4M | -$5M | -$3M |
| Operating Cash Flow | -$6M | -$86M | $322K | -$127M | -$76M |
| — Investing Activities — | |||||
| Capital Expenditures | -$2M | -$2M | -$602K | -$2M | $0 |
| Acquisitions (Net) | $0 | $40K | $175M | $0 | $0 |
| Investment Purchases | -$8M | -$7M | -$257M | -$179M | -$133M |
| Investment Sales | $0 | $7M | $81M | $259M | $183M |
| Other Investing | $0 | $0 | -$175M | $0 | $0 |
| Investing Cash Flow | -$10M | -$2M | -$176M | $78M | $49M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $16M | $1M | $0 | $0 | $0 |
| Financing Cash Flow | $248M | $96M | $880K | $842K | $542K |
| Net Change in Cash | $231M | $8M | -$175M | -$48M | -$27M |
| Cash End of Period | $326M | $334M | $160M | $111M | $85M |
| Free Cash Flow | -$8M | -$87M | -$280K | -$129M | -$76M |